Immunohematology analyzes the reactions that take place between antibodies present in plasma and antigens present on blood cells. For transfusion therapy, patients are tested for their RhD and ABO blood groups and the existence of any antibodies that may result in a reaction between their donor red cells and plasma. A wide range of tests are used to identify and detect antibodies in patients’ plasma from gel tests and simple tube to more complex elution and absorption technology as well as advanced molecular technology. These tests recognize if the antigen is existing on the patient's red cells. People with hematological disorders such as auto immune hemolytic anemia, a wide variety of immune-hematological procedures are used to recognize and determination to the diagnostic problems in these patients. Molecular technologies are widely used in immunohematology to determine the antigen profile of patients, resolve difficult problems, and large-scale red cell typing.
According to the Center for Disease Control and Prevention (CDC), about 450,000 burn injuries need medical care, 40,000 patients are hospitalized, and 3,400 deaths are registered each year in the U.S. Growing number of trauma care centers and rising number of trauma cases are driving the growth of the global immunohematology market. As per a report published by the CDC, trauma is the leading cause of death among the population in the U.S., and it accounts for 30% of deaths in the age group of 1 to 46 years. In the country, about 41 million emergency appointments are registered each year and 2.3 million patients are hospitalized. In addition, burn injuries are projected to accelerate the growth of the market for immunohematology during the forecast period.
The global market for immunohematology is segmented on the basis of product, application, end-user, and region. In terms of product, the market is segmented into immunohematology analyzers and immunohematology reagents. Immunohematology analyzers are developed to meet the unique needs of immunohematology labs through exclusive benefits of responsive automation. Immunohematology reagents include ABO anti sera, Rh(D) anti sera, and other anti sera reagents. In terms of application, the market is categorized into blood-related diseases, HIV, and hepatitis. Blood-related diseases include disorders such as hemophilia, lymphoma, leukemia, anemia, and venous thrombosis. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and blood banks.
Geographically, the market for immunohematology is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for immunohematology owing to increasing incidence of trauma and blood-related diseases, including HIV and hepatitis, early adoption of treatment, and new product innovations. Europe is the second leading market for immunohematology due to expansion and development of more efficient and advanced technologies. Factors such as stringency in blood testing, rise in the adoption rate of immunohematology products, and stringent government regulations to transmission the blood components in the Germany are expected to accelerate the market growth in the region. The Asia Pacific market is anticipated to expand at a high growth rate owing to increasing health care spending and growth in research and development. The market in Australia is gaining pull owing to favorable initiatives of the government. The National Blood Authority involved in several initiatives in order to participate and support from healthcare providers to surge knowledge on minimalize wastage of blood and blood related products, and execution of patient blood management. For instance, National Immunohematology Continuing Education (NICE) committee and National Blood Authority has managed to create awareness through presentations.
Major players operating in the global market for immunohematology are Bio-Rad Laboratories, Inc., Grifols, Immucor, Hologic, Inc., ThermoFisher, Abbott, Roche Diagnostics, Beckman Coulter, Inc., and Becton, Dickinson and Company.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.